The Trump administration is proposing to pay doctors who take Medicare basically the same amount for office visits regardless of reason; the pending sale of Mission Health to HCA Healthcare reflects a national trend as hospitals consolidate at an accelerating pace and the cost of healthcare continues to rise; a closer look at 5 ideas in President Trump's plan to lower drug prices.
The Trump administration is proposing to pay doctors who take Medicare basically the same amount for office visits regardless of reason, a move that CMS says will reduce paperwork but critics say will cause underpayments for complex patients, The New York Times reported. The proposal would pay one rate for new patients and a lower rate for established patients. Ted Okon, the executive director of the Community Oncology Alliance, called the idea “simply crazy." The proposal, part of Medicare’s physician fee schedule for 2019, is to be published Friday in the Federal Register, with an opportunity for public comment until September 10. The new policies would apply to services starting in January.
The pending sale of Mission Health, the largest hospital system in western North Carolina, to HCA Healthcare, the nation’s largest for-profit hospital chain, reflects a national trend as hospitals consolidate at an accelerating pace and the cost of healthcare continues to rise, Kaiser Health News reported. Mission Health provided $100 million in free charity care last year. Residents worry whether the nonprofit hospital will maintain its deep community ties, although the deal would also mean the creation of a large nonprofit foundation that could potentially have close to $2 billion in assets. In addition, HCA will have to pay upward of $10 million in state and local taxes.
After a flurry of pharmaceutical pricing news over the past week, what’s really behind President Trump’s plan to lower drug prices? STAT dissected 5 ideas that seem to be coming to a head, saying some of the ideas on the list are indeed big ones, while other recent announcements are first steps in what will likely incite a regulatory battle against industry players. Others are such small changes as to be effectively meaningless, and other ideas represent an effort to put a new spin on policies that have already been in the works.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen